A GABA receptor agonist is a drug that is an agonist for one or more of the GABA receptors, producing typically sedative effects, and may also cause other effects such as anxiolytic, anticonvulsant, and muscle relaxant effects. There are three receptors of GABA. The GABAA and GABAA-ρ receptors are ion channels that are permeable to chloride ions which reduces neuronal excitability. The GABAB receptor belongs to the class of G protein-coupled receptors that inhibit adenylyl cyclase, therefore leading to decreased cyclic adenosine monophosphate (cAMP). The GABAA receptor mediates sedative, hypnotic, and anticonvulsant effects. The GABAB receptor mediates similar but differing effects.
Types Many commonly used sedative and anxiolytic drugs that affect the GABA receptor complex are not agonists. These drugs act instead as positive allosteric modulators (PAMs) and while they do bind to the GABA receptors, they bind to an allosteric site on the receptor and cannot induce a response from the neuron without an actual agonist being present. Drugs that fall into this class exert their pharmacodynamic action by increasing the effects that an agonist has when potentiation is achieved. General anesthetics act primarily as PAMs of GABA-A receptor. Positive allosteric modulators work by increasing the frequency with which the chloride channel opens when an agonist binds to its own site on the GABA receptor. The resulting increase in the concentration of Cl− ions in the postsynaptic neuron immediately hyperpolarizes this neuron, making it less excitable and thus inhibiting the possibility of an action potential. However, some general anesthetics like propofol and high doses of barbiturates may not only be positive allosteric modulators of GABA-A receptors but also direct agonists of these receptors. Alcohol is an indirect GABA agonist. GABA is the major inhibitory neurotransmitter in the brain, and GABA-like drugs are used to suppress spasms. Alcohol is believed to mimic GABA's effect in the brain, binding to GABA receptors and inhibiting neuronal signaling.
GABAA receptor
Agonists
4-AHP Barbiturates (in high doses) Bamaluzole Benzodiazepines Dihydromuscimol Etomidate GABA Gabamide GABOB Gaboxadol (THIP) Ibotenic acid Imidazole-4-acetic acid (IAA) Isoguvacine Isonipecotic acid Methylglyoxal Muscimol Nefiracetam Picamilon 4-PIOL Piperidine-4-sulfonic acid (P4S) Progabide Propofol Quisqualamine SL-75102 Thiomuscimol Tolgabide
Positive allosteric modulators
Alcohols (e.g., ethanol, isopropanol) Avermectins (e.g., ivermectin) Barbiturates (e.g., phenobarbital) Benzodiazepines (e.g., diazepam) Bromides (e.g., potassium bromide) Carbamates (e.g., meprobamate, carisoprodol) Chloral hydrate, chloralose, petrichloral, and other 2,2,2-trichloroethanol prodrugs Chlormezanone Clomethiazole Dihydroergolines (e.g., ergoloid (dihydroergotoxine)) Etazepine Etifoxine 2-Substituted phenols (e.g., thymol, eugenol) Imidazoles (e.g., etomidate) Kavalactones (found in kava) Loreclezole Neuroactive steroids (e.g., allopregnanolone, ganaxolone) Nonbenzodiazepines (e.g., zaleplon, zolpidem, zopiclone, eszopiclone) Propofol Piperidinediones (e.g., glutethimide, methyprylon) Propanidid Pyrazolopyridines (e.g., etazolate) Quinazolinones (e.g., methaqualone) Skullcap constituents (e.g., Baicalein) Stiripentol Disulfonylalkanes (e.g., sulfonmethane, tetronal, trional) Valerian constituents (e.g., valeric acid, valerenic acid) Volatile organic compounds (e.g., chloroform, diethyl ether, sevoflurane)
GABAB receptor
Agonists 1,4-Butanediol Baclofen GABA Gabamide GABOB gamma-Butyrolactone (GBL) gamma-Hydroxybutyric acid (GHB) gamma-Hydroxyvaleric acid (GHV) gamma-Valerolactone (GVL) Lesogaberan Phenibut 4-Fluorophenibut Picamilon Progabide SL-75102 Tolgabide
Positive allosteric modulators ADX-71441 ASP-8062 CGP-7930
GABAA-ρ receptor
Agonists CACA CAMP GABA GABOB Muscimol N4-Chloroacetylcytosine arabinoside Picamilon Progabide Tolgabide
Positive allosteric modulators Neuroactive steroids (e.g., allopregnanolone, THDOC, alphaxolone)
References
External links GABA+agonists at the U.S. National Library of Medicine Medical Subject Headings (MeSH) MeSH list of agents 82018755


